Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001244560 | SCV001417789 | benign | Adams-Oliver syndrome 5 | 2024-09-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001796412 | SCV002032843 | uncertain significance | not provided | 2021-06-08 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 969258; Landrum et al., 2016); This variant is associated with the following publications: (PMID: 27535533, 26582918) |
Genome- |
RCV001244560 | SCV002553344 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002271199 | SCV002553345 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002348832 | SCV002651206 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2021-08-14 | criteria provided, single submitter | clinical testing | The p.E1826K variant (also known as c.5476G>A), located in coding exon 30 of the NOTCH1 gene, results from a G to A substitution at nucleotide position 5476. The glutamic acid at codon 1826 is replaced by lysine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |